Jae Young Joung
-
- Prostate Cancer Treatment and Research 34
- Renal cell carcinoma treatment 25
- Prostate Cancer Diagnosis and Treatment 12
- Oncology top 10%
- PARP inhibition in cancer therapy 21
- Urology top 5%
- Cancer Research top 10%
- Cancer Genomics and Diagnostics 11
- Surgery top 10%
- Bladder and Urothelial Cancer Treatments 26
- Urinary and Genital Oncology Studies 13
-
- Radiopharmaceutical Chemistry and Applications 9
- Co-authors
- Ho Kyung SeoKang Hyun LeeJinsoo ChungSung Han KimWeon Seo ParkKyung Seok HanKang Su ChoWhi‐An Kwon
- Journals
- The Lancet (1 paper)Journal of Clinical Oncology (14 papers)SHILAP Revista de lepidopterología (1 paper)
- Partner nations
- South KoreaUnited StatesJapan
In The Last Decade
Jae Young Joung
78 papers receiving 910 citations
Hit Papers
Peers
Comparison fields: 5 of 73
- Pulmonary and Respiratory Medicine 589
- Oncology 355
- Urology 83
- Cancer Research 186
- Surgery 287
Countries citing papers authored by Jae Young Joung
This map shows the geographic impact of Jae Young Joung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jae Young Joung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jae Young Joung more than expected).
Fields of papers citing papers by Jae Young Joung
This network shows the impact of papers produced by Jae Young Joung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jae Young Joung. The network helps show where Jae Young Joung may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jae Young Joung, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 2 | |
| 5 | 2023 | 3 | |
| 6 | 2023 | 3 | |
| 7 | 2023 | 7 | |
| 8 | Olaparib plus abiraterone versus placebo plus abiraterone in metastatic castration-resistant prostate cancer (PROpel): final prespecified overall survival results of a randomised, double-blind, phase 3 trialbreakdown → | 2023 | 132 |
| 9 | 2022 | 11 | |
| 10 | 2022 | 6 | |
| 11 | 2021 | 12 | |
| 12 | 2020 | 4 | |
| 13 | 2017 | 1 | |
| 14 | 2016 | 4 | |
| 15 | 2016 | 4 | |
| 16 | 2016 | 30 | |
| 17 | 2016 | 19 | |
| 18 | A Rapidly Progressing Bladder Transitional Cell Carcinoma with Sarcomatoid Deferrentiation | 2010 | 0 |
| 19 | 2010 | 11 | |
| 20 | 2008 | 11 |
About Jae Young Joung
Jae Young Joung is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Urology, having authored 83 papers that have together received 929 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (34 papers), Bladder and Urothelial Cancer Treatments (26 papers), Renal cell carcinoma treatment (25 papers), PARP inhibition in cancer therapy (21 papers), Urinary and Genital Oncology Studies (13 papers), Prostate Cancer Diagnosis and Treatment (12 papers), Cancer Genomics and Diagnostics (11 papers) and Radiopharmaceutical Chemistry and Applications (9 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (589 citations), Oncology (355 citations) and Urology (83 citations). Jae Young Joung has collaborated with scholars based in South Korea, United States and Japan. Frequent co-authors include Ho Kyung Seo, Kang Hyun Lee, Jinsoo Chung, Sung Han Kim, Weon Seo Park, Kyung Seok Han, Kang Su Cho, Whi‐An Kwon, Fred Saad and Neal D. Shore. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.